Phase 1 Mesenchymal Stem Cells Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
Chronic PancreatitisMesenchymal Stem Cells
Medical University of South Carolina42 enrolled1 locationNCT05095532
Recruiting
Phase 1Phase 2
Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis
Mesenchymal Stem CellsSclerosis, Systemic
Marie Hudson, MD18 enrolled1 locationNCT04356287
Recruiting
Phase 1Phase 2
HUC-MSC for Treatment of High-risk HPV Infection
Human Papillomavirus VirusesMesenchymal Stem Cells
Shanghai East Hospital60 enrolled1 locationNCT06610773